Advanced Breast Cancer: Living Well Through Information and Support – New Evening Time! Understand the latest research and treatment advances and learn how to improve your quality of life during our this teleconference series.
Speakers: William J. Gradishar, MD, FACP; Patricia S. Steeg, PhD and Lillie D. Shockney, RN, BS, MAS
Register for part or all of the advanced breast cancer teleconference series.
Teleconference series, Advanced Breast Cancer: Living Well Through Information and Support, on Wednesday, October 14, Wednesday, October 21, and Thursday, November 5. All teleconferences will be held from 8:00pm to 9:15pm (Atlantic)/8:30pm to 9:45pm (Newfoundland).
Part 1, Treatment Update: Medical and Quality-of-Life News, will provide you with information on recent clinical trial findings and the latest research. Speaker William J. Gradishar, MD, FACP, will also give you practical advice on how to manage symptoms and side effects.
During Part 2, speaker Patricia S. Steeg, PhD, will talk about Research and You: Understanding Clinical Trials. She will discuss topics such as:
How to access clinical trials
What trials are available for women living with metastatic disease
The benefits and risks of participating in clinical trials
The latest research on breast cancer metastasis
During Part 3, Living Fully: Making Treatment Decisions, speaker Lillie D. Shockney, RN, BS, MAS, will discuss how to have the best quality of life while living with advanced breast cancer, including:
How to make the right treatment decisions for you
How to communicate your short-term and long-term goals with your loved ones
How to adapt to a changing treatment plan
About Our Speakers
Dr. Gradishar is professor of medicine in the division of hematology and medical oncology at the Feinberg School of Medicine at Northwestern University. He is also a member of the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and serves as director of breast medical oncology, associate director of the Lynn Sage Comprehensive Breast Program and program director of Northwestern University’s hematology/oncology fellowship training program. His research focuses on the development of new therapies for breast cancer treatment. He is a reviewer for numerous journals and has published many articles on breast cancer therapies.
Dr. Steeg is chief of the women’s cancers section of the laboratory of molecular pharmacology in the Center for Cancer Research at the National Cancer Institute (NCI). She leads treatment development efforts by focusing on the molecular aspects of tumor metastasis. Dr. Steeg serves as president of the Metastasis Research Society and deputy editor of Clinical Cancer Research. She has won many awards, including NCI’s Outstanding Mentor Award in 2005 and Susan G. Komen for the Cure’s 2008 Brinker Award for Scientific Distinction in Basic Science.
Lillie D. Shockney is University Distinguished Service Assistant Professor of Breast Cancer and assistant professor in the departments of surgery and gynecology at John Hopkins University School of Medicine. She is also an assistant professor at John Hopkins School of Nursing and co-founder and vice president of the national nonprofit organization Mothers Supporting Daughters with Breast Cancer. Ms. Shockney is a published author and nationally recognized public speaker on breast cancer and serves on the medical advisory board of several national breast cancer organizations. She is the recipient of numerous leadership and community service awards and was selected as one of the Top 100 Women in Maryland for her leadership and community service efforts. Dr. Shockney’s research interests include quality of life issues for survivors.
About the Program
Both teleconferences will feature a presentation by the speaker, followed by a 45-minute question-and-answer session. To participate, you need only a telephone or computer (listen-only) with Real Network Player or Windows Media Player. Social workers may be eligible to receive continuing education credits; see our registration form for more details.
The teleconferences are free, but pre-registration by October 7 is required.
Source: Atlantic Breast Cancer Net